| abstract |
Novel triazolopyrimidines of the formula I <IMAGE> in which -A-B-C-D- and R<1> have the meanings given in Patent Claim 1, and their salts show angiotensin II-antagonistic properties and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and increased intraocular pressure as well as of disorders of the central nervous system. |